Hui Hao Lu

Directeur/Bestuurslid bij ZHEJIANG ANGLIKANG PHARMACEUTICAL CO.,LTD.

Vermogen: 17 M $ op 30-04-2024

54 jaar

Health Technology

Profiel

Hui Hao Lu has worked as a Director and Deputy General Manager at Zhejiang Anglikang Pharmaceutical Co. Ltd.
since 2014.
He is also currently a Director at Hunan Kerey Pharmaceutical Co., Ltd.

Bekende belangen in openbare bedrijven

Onderneming	Datum	Aantal aandelen	Totale waarde	Waarderingsdatum
ZHEJIANG ANGLIKANG PHARMACEUTICAL CO. LTD. 33.07%	30-09-2022	5 440 219 ( 33.07% )	13 M $	30-04-2024
ZHEJIANG ANGLIKANG PHARMACEUTICAL CO. LTD. CLASS A 0.98%	30-09-2022	1 813 406 ( 0.98% )	4 M $	30-04-2024

Actieve functies van Hui Hao Lu

Bedrijven	Functie	Begin
ZHEJIANG ANGLIKANG PHARMACEUTICAL CO.,LTD.	Directeur/Bestuurslid	09-12-2014
Hunan Kerey Pharmaceutical Co., Ltd. Hunan Kerey Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hunan Kerey Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates. Its products include special active pharmaceutical ingredients, plant-origin cholesterol and vitamin D, plant-origin cholic acids, brassinolides, and key intermediates. The company was founded in 2005 and is headquartered in Shaoyang, China.	Directeur/Bestuurslid	-